Compounds > isoproterenol

isoproterenol and lapatinib

isoproterenol has been researched along with lapatinib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Bedja, D; Belmonte, F; Gabrielson, K; Guo, X; Kang, B; Pin, S; Sysa-Shah, P; Tsuchiya, N; Xu, Y1
Chang, WT; Feng, YH; Lee, K; Liu, PY; Wu, SN1

Reviews

1 review(s) available for isoproterenol and lapatinib

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for isoproterenol and lapatinib

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Animals; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Cell Survival; Electrophysiological Phenomena; Gene Expression; Isoproterenol; Lapatinib; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Organ Size; Organ Specificity; Protein Biosynthesis; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction

2012
Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes.
    International journal of molecular sciences, 2020, Feb-29, Volume: 21, Issue:5

    Topics: Action Potentials; Animals; Humans; Ion Channels; Ion Transport; Isoproterenol; Lapatinib; Mice; Myocytes, Cardiac; Neoplasms; Potassium; Potassium Channels; Protein Kinase Inhibitors; Rats; Sodium; Sorafenib

2020